A2-Ai
Home
LeadershipBlogCareersGet in touch
All posts Category / news

Tags

ADMEAIanimal testingapproval processclinical pharmacologyclinical trialscloud platformdata analysisdose escalationdrug developmentFDAIND
see all RSS

Simonne Bruck

Business Manager

April 30, 2025

MIDD - FDA Has Officially Announced Their Roadmap to Phase Out Animal Testing for Monoclonal Antibodies

news

Links

Home Leadership Careers Contact Blog

Pharmaceutical

FDA Project Optimus Preclinical Support Clinical Pharmacology Pharmacometrics Education

Technology

Overview A2-Ai Cloud

Resources

Attributions

Community

LinkedIn GitHub RSS
A2-Ai

A2-Ai is a premier full-service consultancy run by leaders who put science and patients first, with a focus on providing true value to our clients.

® A2-Ai LLC 2023

2723 S. State Street
Suite 310
Ann Arbor, MI 48104